154 / 180
310
2012; 73: 149–52.
29. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L,
Acampora D, Holford TR, Cooney LM Jr. A multicomponent
intervention to prevent delirium in hospitalized older patients. N
Engl J Med. 1999;340(9):669-76.
30. Yue J, Tabloski P, Dowal SL, Puelle MR, Nandan R, Inouye SK.
The National Institute for Health and Clinical Excellence (NICE)
to Hospital Elder Life Program (HELP): Operationalizing Nice
Guidelines to Improve Clinical Practice. J Am Geriatr Soc. 2014;
62(4): 754–761.
31. Hshieh TT, Yue J, Oh E, et al. Effectiveness of multi-component
non-pharmacologic delirium interventions: A Meta-analysis.
JAMA internal medicine. 2015;175(4):512-520.
32. Siddiqi N, Harrison JK, Clegg A, Teale EA, Young J, Taylor J, Simpkins
SA. Interventions for preventing delirium in hospitalised non-ICU
patients. Cochrane Database Syst Rev. 2016;3:CD005563.
33. Campbell N, Boustani MA, Ayub A, et al. Pharmacological
management of delirium in hospitalized adults--a systematic
evidence review. Journal of general internal medicine.
2009;24(7):848-853.
34. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for
delirium. Cochrane Database Syst Rev. 2007(2):CD005594.
35. Siddiqi N, Stockdale R, Britton AM, Holmes J. Interventions for
preventing delirium in hospitalised patients. Cochrane Database
Syst Rev.2007(2):CD005563.
36. Lawrence KR, Nasraway SA. Conduction disturbances associated
with administration of butyrophenone antipsychotics in the
critically ill: a review of the literature. Pharmacotherapy
1997;17(3):531-537.
37. Clinical Review from Drug and Therapeutics Bulletin. QT interval
and drug therapy. BMJ 2016;353: i2732.
38. Schneider LS, Dagerman KS, Insel P. Risk of death with
atypical antipsychotic drug treatment for dementia: meta-
analysis of randomized placebo-controlled trials. JAMA
2005;294(15):1934-1943.
39. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for
delirium. Cochrane Database Syst Rev. 2007(2):CD005594.
40. Breitbart W, Marotta R, Platt MM, et al. A double-blind trial of
Haloperidol, chlorpromazine, and Lorazepam in the treatment
of delirium in hospitalized AIDS patients. The American journal
of psychiatry.1996;153(2):231-237.
41. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs
midazolam for sedation of critically ill patients: a randomized
trial. JAMA 2009;301(5):489-499.
[REV. MED. CLIN. CONDES - 2017; 28(2) 301-310]